Kuehne + Nagel has announced a strategic partnership with Jointown, one of China’s largest non-state-owned pharmaceutical distribution company, to accelerate its footprint in pharma and healthcare logistics in China.
The partnership will grant Kuehne + Nagel access to Jointown’s GxP-compliant, in-country storage and distribution network, enabling Kuehne + Nagel to comply with the highly regulated Chinese pharma & healthcare sector.
“We are pleased to be partnering with Jointown. Our cooperation perfectly meets the demands of our global clientele by enabling seamless supply chain coverage connecting China. This will enable us to accelerate our growth in the pharma and healthcare sector in China,” said Siewloong Wong, President of Kuehne + Nagel Asia Pacific.
With Covid-19 vaccines approved for use in more countries, Jointown and Kuehne + Nagel will collaborate to manage vaccine distribution, leveraging their respective strengths in vaccine storage and distribution in China and other parts of the world.
The partnership with Jointown comes shortly after Kuehne + Nagel announced that it has entered into a binding agreement to acquire the Chinese company Apex International Corporation, one of Asia’s leading freight forwarders.
Source: Kuehne + Nagel